Europe Diagnostic Imaging Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Europe Diagnostic Imaging Market Trends and Insights

Prevalence of chronic diseases and an aging European population

Europe’s over-65 cohort is on track to jump from 21% in 2023 to 29% by 2050, translating into millions more oncology, cardiology, and musculoskeletal scans each year.^{[1]Source: OECD, “Health at a Glance Europe 2024,” OECD Publishing, oecd.org} Cancer incidence already exceeds 4.47 million new cases annually, with Northern and Western countries detecting disease earlier thanks to organized screening. Hospitals respond by prioritizing multipurpose scanners that handle high daily volumes yet deliver sub-millimetric resolution. Vendors cater to this surge with wider bore MRI and low-dose CT lines that preserve image quality for frail patients. Chronic disease management programs also drive sustained outpatient imaging referrals, re-orienting procurement toward scalable, cloud-connected systems that streamline image sharing among referring physicians.

Continuous technology innovation in imaging

Photon-counting CT provides up to four-fold higher spatial resolution and significantly lower radiation dose than conventional detectors, winning early adopters at sites such as San Raffaele Hospital in Italy. AI-aided reconstruction on Siemens Healthineers’ Helium-free MRI platform cuts exam times by 30%, enabling more scans per day and easing scheduling backlogs. France earmarked EUR 1.5 billion for healthcare AI, and early pilots show a 28% improvement in tumor detection with AI-assisted mammography. These breakthroughs spark modality replacement even in budget-tight environments because operational savings offset frontline price premiums. Vendors complement hardware with subscription-based AI suites that automate repetitive tasks and support remote reading.

Rising healthcare infrastructure investment and hospital modernization programs

Germany’s Hospital Future Act injects more than EUR 4 billion into digital upgrades across 1,624 hospitals, with imaging IT and scanner fleets ranking among the top spending categories. Value partnerships, such as the 12-year EUR 55 million agreement between Siemens Healthineers and University Hospital Nantes, bundle multiple CT, MRI, and ultrasound units with service and staff-training commitments. Capital programs aim to shrink wait lists and elevate diagnostic standards, prompting large multiyear tenders that reward suppliers able to integrate imaging chains into hospital enterprise platforms. Modernization also positions facilities to qualify for future outcome-based reimbursement models that depend on accurate, timely diagnostics.

Growing adoption of minimally invasive, image-guided procedures across specialties

Surgeons and interventional radiologists increasingly rely on live imaging to navigate catheters, ablation probes, and robotic tools, reducing patient trauma and length of stay. Evidence from lumbar spine interventions shows minimally invasive image-guided treatments lower operating room time and post-operative complications compared with open surgery. Nuclear medicine leverages diagnostic scans to personalize therapies, typified by the French reimbursement green light for 177Lu-PSMA prostate cancer treatment that pairs PET imaging with targeted radiopharmaceuticals. The procedural shift accelerates demand for hybrid operating suites equipped with high-resolution fluoroscopy, cone-beam CT, and ultrasound systems capable of real-time fusion imaging.

High capital and total-cost-of-ownership for advanced imaging equipment

Photon-counting CT and 3 T MRI units can top USD 1 million apiece, while annual service contracts often equal 10% of purchase price. EU MDR compliance adds incremental pre-market expenditure exceeding USD 50,000 for Class III devices and can lengthen time-to-market, delaying revenue realization for manufacturers and limiting early access for providers.^{[2]Source: EuroDev, “The Cost of Obtaining EU MDR Certification,” eurodev.com} Smaller clinics struggle to justify such outlays under fixed reimbursement, potentially widening geographic gaps in care.

Persistent shortage of radiologists and imaging technologists

United Kingdom surveys show 75% of imaging departments operating with unfilled consultant posts, forcing reliance on locum staff and teleradiology outsourcing. Across Europe, technologist vacancy rates climbed to 18.1% in 2024 from 6.2% three years earlier, inflating labor costs and elongating patient queues. AI triage tools and remote reading networks help mitigate pressure yet cannot fully replace experienced personnel for complex procedures.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Modality: MRI momentum reshapes diagnostic priorities

X-ray retained the largest slice of the Europe diagnostic imaging market at 35.02% in 2025, anchored by ubiquitous use in trauma and primary care. That dominance is stable through mid-term forecasts, but MRI’s 7.12% CAGR represents the fastest lane, supported by helium-free magnet technology that removes bulk cryogen logistics and trims lifecycle emissions. Photon-counting CT shipments also accelerate thanks to oncology staging protocols demanding finer lesion characterization. Ultrasound remains indispensable in cardiac, obstetric, and point-of-care settings; 80% of Belgian emergency departments already use portable scanners for bedside triage. Nuclear imaging slots into theranostic regimens, while digital mammography enjoys AI decision support that lifts cancer detection sensitivity.

MRI’s share growth reshapes vendor R&D budgets toward advanced coils, motion correction, and compressed sensing. X-ray manufacturers counter by integrating AI fracture detection and dual-energy functionality. CT suppliers bundle dose-tracking dashboards to satisfy tightening radiation governance. Segment players that deliver comprehensive modality ecosystems—hardware, software, and service—capture recurring revenue themes and deepen account stickiness within the Europe diagnostic imaging market.

By Portability: mobility bridges access gaps

Fixed systems still represent 78.61% of installed base and remain indispensable for high-throughput oncology and trauma centers. These suites house ceiling-suspended detectors, 64-slice CT, and 3 T MRI that anchor multidisciplinary hubs. Yet shifting care models favor agile solutions, propelling mobile and handheld systems at 6.82% CAGR. The Europe diagnostic imaging market size for portable ultrasound is projected to climb above USD 1.29 billion by 2031 as general practitioners and paramedics adopt pocket devices that expedite triage in ambulances and rural clinics. Chipiron’s USD 17 million funding to engineer compact MRI underlines investor belief in mobility’s disruptive potential.

Mobile CT and C-arms also align with surgical suite expansion and trauma resuscitation bays that demand rapid imaging without patient transfer. Vendors refine battery life, wireless data transfer, and antimicrobial casings to support infection-control protocols. Meanwhile, leasing firms offer pay-per-scan models that remove upfront capital hurdles, especially for small hospitals, and fuel broader diffusion across the Europe diagnostic imaging market.

By Application: cardiology presses oncology’s leadership

Oncology retained a 25.05% revenue share in 2025 as cancer screening programs and precision radiotherapy planning rely on multi-modality assessments. However, cardiology posts the quickest climb at 6.55% CAGR through improved CT-based coronary evaluation and stress MRI protocols. The Europe diagnostic imaging market share for cardiac imaging is set to expand as 45-minute comprehensive scans replace multiple standalone tests, heightening throughput efficiency. Neurology benefits from AI-assisted stroke triage projects like the EUR 26.9 million UMBRELLA consortium that supplies real-time decision support. Orthopedics exploits cone-beam CT and metal artifact reduction software to refine implant planning.

Cross-specialty demand diversifies product roadmaps. Oncology-focused advances in spectral CT spill into cardiology plaque analysis, while high-frame-rate ultrasound designed for electrophysiology also serves pediatric clinics. Vendors that leverage modular platforms to address overlapping clinical protocols gain cost advantages and shorten development cycles within the Europe diagnostic imaging market.

By End User: Independent imaging centers scale up

Hospitals commanded 70.55% of spending in 2025 owing to broad case mixes and emergency care, yet diagnostic imaging centers post a 7.58% CAGR as they provide faster appointments and transparent pricing. Private capital owns up to 20% of French outpatient imaging practices, injecting funds for scanner upgrades and expansion into neighboring countries. The Europe diagnostic imaging market size allocated to these centers is forecast to substantially grow by 2031 because value-based insurers steer non-acute exams away from costlier hospital settings. Evidia’s merger creates a 100-plus site network that negotiates volume discounts on multi-year equipment contracts.

Academic institutions and contract research organizations also ramp imaging budgets to support clinical trials for personalized therapies, while mobile fleets provide overflow capacity during refurbishment projects. End-user diversity pushes vendors to craft flexible financing, uptime guarantees, and AI-driven fleet management dashboards to attract long-term service revenue from the Europe diagnostic imaging market.

Geography Analysis

Germany dominated the market by acquiring a market share of 27.92% in 2025; it further dominates procurement thanks to industrial depth and clinical research density. France is projected to grow at the fastest CAGR rate of 5.72% from 2026 to 2031. France follows with its EUR 7.5 billion Health Innovation Plan that earmarks EUR 2.4 billion for digital applications, including AI-ready imaging archives. Partnerships such as Philips-Evidia installations in Uppsala position Nordic private clinics at the forefront of sustainable MRI fleet renewal.

The UK struggles with radiologist deficits that stretch reading times, prompting aggressive teleradiology outsourcing and AI prioritization in the national imaging strategy. Spain and Italy deploy mobile multi-screening buses to reach rural populations and cut carbon footprints by 97%. The Netherlands and Denmark enjoy near-universal enterprise PACS adoption and lead in cloud image exchange, providing fertile ground for AI start-ups that integrate with national health identifiers. Central and Eastern European states lag in scanner density but post double-digit growth as EU structural funds subsidize equipment upgrades. Cross-border data regulations spur interest in federated AI that trains algorithms locally without sharing patient images, supporting compliant innovation adoption across the Europe diagnostic imaging market. Vendors that tailor financing models and service networks to local reimbursement schemes better capture demand diversity.

Regulatory Landscape

Diagnostic imaging equipment in Europe is regulated primarily under the EU Medical Devices Regulation (MDR, Regulation (EU) 2017/745), with CE marking tied to conformity assessment routes that often involve notified bodies for higher-risk systems and certain software. In May 2026, the European Commission adopted Implementing Regulation (EU) 2026/977 to standardize quality management and procedural requirements for notified body conformity assessments under MDR/IVDR, with application from February 2027, adding clearer process anchors for manufacturers planning EU-wide launches.

The compliance environment is also moving toward more structured support and harmonization. In April 2026, the European Medicines Agency (EMA) launched a breakthrough medical device pilot program to provide priority scientific advice and enhanced regulatory support for innovative high-risk (Class III) and active Class IIb devices, relevant to advanced imaging technologies and associated clinical software. In June 2026, the European Commission issued an implementing decision on harmonised European standards for medical devices, while July 2026 marks the start of the first Joint Clinical Assessments (JCAs) for medical devices under the new EU evaluation framework, increasing emphasis on EU-level evidence alignment alongside national access pathways.

Market Opportunities and Future Outlook

Hospital modernization programs and longer-duration value partnerships continue to create whitespace for fleet-wide replacement and multi-modality standardization, especially where buyers bundle scanners with installation, training, and uptime commitments. A concrete example is Siemens Healthineers 10-year, EUR 22 million agreement with Hospiten (announced April 2026) to equip the new Boadilla (Madrid) hospital with more than 25 devices, including 3T MRI and photon-counting CT, showing how vendors can gain share by packaging advanced modalities with long-term service and workflow outcomes.

Capacity building around advanced diagnostics, especially PET/CT, is also becoming a tangible adjacent opportunity, since equipment utilization depends on dependable tracer supply and integrated patient pathways. Siemens Healthineers announced a GBP 26 million investment (July 2026) in a high-capacity radiopharmacy in Dunstable, UK, designed for 8x the output of conventional facilities, directly supporting PET imaging throughput and reliability for provider networks. On the equipment side, financing-backed industrial scale-up points to continued room for European manufacturing and innovation in digital radiology: DMS Group secured up to EUR 20 million from the European Investment Bank via InvestEU (March 2026) to accelerate next-generation digital radiology and bone densitometry development and expand capacity at its Gallargues-le-Montueux site. Regulatory process standardization, including the May 2026 implementing regulation for notified body assessments (applicable February 2027), is further sharpening attention on evidence readiness and quality system maturity as differentiators for imaging OEMs and software suppliers.